| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CoA-ligase activity | 2.32e-04 | 27 | 89 | 3 | GO:0016405 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.60e-04 | 127 | 89 | 5 | GO:0016616 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 3.52e-04 | 31 | 89 | 3 | GO:0016878 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 3.82e-04 | 138 | 89 | 5 | GO:0016614 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 4.09e-04 | 78 | 89 | 4 | GO:0003725 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | PDIA4 FMO4 TXNDC5 DHRS9 SDR42E1 MDH1 FADS2B HIBADH TET3 HEPH AKR7A2 | 5.90e-04 | 766 | 89 | 11 | GO:0016491 |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 8.07e-04 | 41 | 89 | 3 | GO:0016877 | |
| Domain | EIF3C_N_dom | 2.14e-05 | 2 | 87 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 2.14e-05 | 2 | 87 | 2 | PF05470 | |
| Domain | EIF3C | 2.14e-05 | 2 | 87 | 2 | IPR027516 | |
| Domain | AMP-binding | 3.62e-04 | 30 | 87 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 3.62e-04 | 30 | 87 | 3 | IPR000873 | |
| Domain | - | 5.43e-04 | 218 | 87 | 6 | 1.10.10.10 | |
| Domain | Disulphide_isomerase | 5.90e-04 | 8 | 87 | 2 | IPR005788 | |
| Domain | TPR-like_helical_dom | 7.69e-04 | 233 | 87 | 6 | IPR011990 | |
| Domain | WHTH_DNA-bd_dom | 9.36e-04 | 242 | 87 | 6 | IPR011991 | |
| Domain | Thioredoxin | 1.62e-03 | 13 | 87 | 2 | IPR005746 | |
| Domain | PINT | 2.47e-03 | 16 | 87 | 2 | SM00088 | |
| Domain | PCI_dom | 2.79e-03 | 17 | 87 | 2 | IPR000717 | |
| Domain | PCI | 2.79e-03 | 17 | 87 | 2 | PF01399 | |
| Domain | Thioredoxin_CS | 2.79e-03 | 17 | 87 | 2 | IPR017937 | |
| Domain | - | 2.82e-03 | 207 | 87 | 5 | 1.25.40.10 | |
| Domain | ZnF_RBZ | 5.09e-03 | 23 | 87 | 2 | SM00547 | |
| Domain | TUDOR | 5.09e-03 | 23 | 87 | 2 | PS50304 | |
| Domain | Znf_RanBP2 | 6.00e-03 | 25 | 87 | 2 | IPR001876 | |
| Domain | THIOREDOXIN_1 | 6.00e-03 | 25 | 87 | 2 | PS00194 | |
| Domain | AMP-binding_CS | 6.48e-03 | 26 | 87 | 2 | IPR020845 | |
| Domain | TUDOR | 6.98e-03 | 27 | 87 | 2 | SM00333 | |
| Domain | TPR_REGION | 7.41e-03 | 165 | 87 | 4 | PS50293 | |
| Domain | TPR | 7.41e-03 | 165 | 87 | 4 | PS50005 | |
| Domain | AMP_BINDING | 7.49e-03 | 28 | 87 | 2 | PS00455 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSPD1 PDIA4 SLC25A24 RANBP2 GNL3L TXNDC5 SBNO1 ABCE1 FANCI GARS1 SLTM HMGB1 OAT EIF3C TDRD6 MDH1 CTTN AP3B1 ADAR NEK9 SDAD1 EIF3CL PPP1CA FTSJ3 | 1.77e-13 | 1425 | 91 | 24 | 30948266 |
| Pubmed | HSPD1 PDIA4 RANBP2 TXNDC5 ABCE1 GARS1 HMGB1 OAT DDX60L EIF3C TNS1 SDAD1 ACSL5 SLC27A2 | 4.91e-09 | 711 | 91 | 14 | 33022573 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | PDIA4 RANBP2 ABCE1 PRRC2C CAPG GARS1 H1-5 HMGB1 OAT EIF3C CTTN HIBADH HMGB1P1 | 6.78e-09 | 607 | 91 | 13 | 39147351 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 PDIA4 RANBP2 TXNDC5 PRRC2C FANCI GARS1 HMGB1 MDH1 CTTN AP3B1 ADAR NEK9 EIF3CL PPP1CA AKR7A2 FTSJ3 | 6.80e-09 | 1149 | 91 | 17 | 35446349 |
| Pubmed | 6.91e-09 | 152 | 91 | 8 | 34299191 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | STK10 ABCE1 RBL2 FER OAT DDX60L EIF3C CTTN TNS1 NEK9 ARAF SDAD1 EIF3CL PPP1CA AKR7A2 | 1.42e-08 | 910 | 91 | 15 | 36736316 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSPD1 PDIA4 SLC25A24 ZMPSTE24 TXNDC5 ABCE1 CNTRL GARS1 H1-5 SLTM HMGB1 MDH1 AP3B1 PPP1CA | 2.40e-08 | 807 | 91 | 14 | 30575818 |
| Pubmed | HSPD1 PDIA4 MFAP1 RANBP2 ZMPSTE24 MYO1A SBNO1 PRRC2C SPEF2 ITSN1 CNTRL GARS1 H1-5 HMGB1 ATG4C CTTN CFAP46 PPP1CA | 3.14e-08 | 1442 | 91 | 18 | 35575683 | |
| Pubmed | 6.59e-08 | 203 | 91 | 8 | 35012549 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSPD1 SLC25A24 MFAP1 GNL3L PRRC2C GARS1 H1-5 SLTM HMGB1 OAT CTTN ADAR SDAD1 EIF3CL PPP1CA FTSJ3 | 1.57e-07 | 1257 | 91 | 16 | 36526897 |
| Pubmed | PDIA4 RANBP2 ABCE1 PRRC2C FANCI OAT EIF3C ADAR HIBADH NEK9 AKR7A2 | 1.58e-07 | 534 | 91 | 11 | 35032548 | |
| Pubmed | HSPD1 RANBP2 GNL3L PRRC2C FANCI H1-5 HMGB1 OAT DDX60L EIF3C MDH1 CTTN STX17 HPSE SDAD1 SLC27A2 PPP1CA | 1.77e-07 | 1440 | 91 | 17 | 30833792 | |
| Pubmed | 2.16e-07 | 329 | 91 | 9 | 35562734 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | HSPD1 RANBP2 ABCE1 PRRC2C H1-5 SLTM EIF3C ARAF SDAD1 EIF3CL PPP1CA FTSJ3 | 3.02e-07 | 701 | 91 | 12 | 30196744 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 5.35e-07 | 182 | 91 | 7 | 30711629 | |
| Pubmed | PDIA4 RANBP2 TXNDC5 FANCI SLTM PPP1R13B HMGB1 EIF3C AP3B1 STX17 TNS1 SDAD1 PPP1CA FTSJ3 | 5.84e-07 | 1049 | 91 | 14 | 27880917 | |
| Pubmed | 8.26e-07 | 503 | 91 | 10 | 16964243 | ||
| Pubmed | HSPD1 DIP2A DZANK1 PRRC2C ITSN1 HMGB1 OAT EIF3C MDH1 CTTN AP3B1 TNS1 EIF3CL PPP1CA DNAH11 SYNGAP1 | 8.78e-07 | 1431 | 91 | 16 | 37142655 | |
| Pubmed | PDIA4 MFAP1 SBNO1 ABCE1 SLTM HMGB1 NUB1 EIF3C AP3B1 ADAR NEK9 | 1.14e-06 | 653 | 91 | 11 | 33742100 | |
| Pubmed | HSPD1 RANBP2 DZANK1 TXNDC5 ABCE1 PRRC2C H1-5 OAT EIF3C CTTN EIF3CL PPP1CA AKR7A2 SYNGAP1 | 1.54e-06 | 1139 | 91 | 14 | 36417873 | |
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 1.77e-06 | 138 | 91 | 6 | 37506885 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | HSPD1 PDIA4 GNL3L NDC80 PRRC2C H1-5 HMGB1 EIF3C CTTN AP3B1 ADAR HMGB1P1 | 2.18e-06 | 847 | 91 | 12 | 35235311 |
| Pubmed | MFAP1 RANBP2 SBNO1 ABCE1 FANCI CAPG H1-5 SLTM HMGB1 MDH1 CTTN ADAR PPP1CA | 2.39e-06 | 1014 | 91 | 13 | 32416067 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 2.53e-06 | 329 | 91 | 8 | 34316702 | |
| Pubmed | 2.89e-06 | 335 | 91 | 8 | 15741177 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 2.95e-06 | 580 | 91 | 10 | 35676659 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 3.22e-06 | 153 | 91 | 6 | 26365490 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 4.08e-06 | 247 | 91 | 7 | 32989298 | |
| Pubmed | O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. | 4.90e-06 | 254 | 91 | 7 | 36604567 | |
| Pubmed | 5.37e-06 | 486 | 91 | 9 | 20936779 | ||
| Pubmed | Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells. | 6.77e-06 | 2 | 91 | 2 | 16732323 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 16176974 | ||
| Pubmed | Involvement of PU.1 in mouse adar-1 gene transcription induced by high-dose esiRNA. | 6.77e-06 | 2 | 91 | 2 | 19422845 | |
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 6.77e-06 | 2 | 91 | 2 | 36157221 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 17435217 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 10921917 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 17606629 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HSPD1 PDIA4 GNL3L H1-5 SLTM UTP23 EIF3C CTTN ADAR EIF3CL PPP1CA FTSJ3 | 6.94e-06 | 949 | 91 | 12 | 36574265 |
| Pubmed | Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins. | 7.71e-06 | 15 | 91 | 3 | 9630982 | |
| Pubmed | 7.71e-06 | 15 | 91 | 3 | 27930333 | ||
| Pubmed | BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. | 7.71e-06 | 15 | 91 | 3 | 12931191 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HSPD1 MFAP1 RANBP2 ABCE1 GARS1 H1-5 UTP23 HMGB1 OAT AP3B1 ADAR EIF3CL PPP1CA FTSJ3 | 8.23e-06 | 1318 | 91 | 14 | 30463901 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | HSPD1 PDIA4 RANBP2 TXNDC5 ABCE1 FANCI H1-5 OAT EIF3C CTTN AP3B1 ARAF | 9.01e-06 | 974 | 91 | 12 | 28675297 |
| Pubmed | HSPD1 PDIA4 MFAP1 GNL3L TXNDC5 GARS1 HMGB1 EIF3C AP3B1 ENO3 HMGB1P1 PPP1CA FTSJ3 | 9.54e-06 | 1153 | 91 | 13 | 29845934 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RANBP2 ABCE1 PRRC2C HMGB1 EIF3C CTTN AP3B1 ENO3 EIF3CL FTSJ3 | 9.76e-06 | 665 | 91 | 10 | 30457570 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 MFAP1 RANBP2 GNL3L ABCE1 FANCI GARS1 H1-5 SLTM DDX60L ADAR NEK9 PPP1CA FTSJ3 | 1.11e-05 | 1353 | 91 | 14 | 29467282 |
| Pubmed | 1.46e-05 | 551 | 91 | 9 | 34728620 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPD1 RANBP2 TXNDC5 SBNO1 PRRC2C GARS1 H1-5 EIF3C MDH1 CTTN AP3B1 NEK9 PPP1CA FTSJ3 | 1.82e-05 | 1415 | 91 | 14 | 28515276 |
| Pubmed | A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro. | 2.03e-05 | 3 | 91 | 2 | 23770722 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 36599932 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 19826001 | ||
| Pubmed | The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. | 2.03e-05 | 3 | 91 | 2 | 8384581 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 18173740 | ||
| Pubmed | The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. | 2.03e-05 | 3 | 91 | 2 | 9748248 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 28415748 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 PDIA4 TXNDC5 SBNO1 ABCE1 FANCI GARS1 H1-5 EIF3C CTTN AP3B1 NEK9 EIF3CL PPP1CA | 2.48e-05 | 1455 | 91 | 14 | 22863883 |
| Pubmed | 2.61e-05 | 132 | 91 | 5 | 22496890 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | PDIA4 SBNO1 FANCI CNTRL GARS1 EIF3C AP3B1 NEK9 SLC27A2 FTSJ3 | 2.86e-05 | 754 | 91 | 10 | 33060197 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 3.04e-05 | 605 | 91 | 9 | 28977666 | |
| Pubmed | PDIA4 STK10 RANBP2 TXNDC5 ABCE1 PRRC2C FANCI CAPG GARS1 H1-5 HMGB1 ADAR | 3.07e-05 | 1103 | 91 | 12 | 34189442 | |
| Pubmed | 3.21e-05 | 340 | 91 | 7 | 29478914 | ||
| Pubmed | HSPD1 PDIA4 ZMPSTE24 TXNDC5 PRRC2C GARS1 H1-5 SLTM HMGB1 OAT ADAR PPP1CA AKR7A2 | 3.27e-05 | 1297 | 91 | 13 | 33545068 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 RANBP2 GNL3L ABCE1 PRRC2C OAT EIF3C CTTN ADAR NEK9 FTSJ3 | 3.30e-05 | 934 | 91 | 11 | 33916271 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 3.71e-05 | 477 | 91 | 8 | 31300519 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MFAP1 SETDB1 DZANK1 NPHP3 TXNDC5 SBNO1 GARS1 HMGB1 AP3B1 NEK9 ARAF EIF3CL PPP1CA | 3.95e-05 | 1321 | 91 | 13 | 27173435 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HSPD1 MFAP1 RANBP2 PRRC2C FANCI SLTM HMGB1 CTTN ADAR HMGB1P1 FTSJ3 | 4.00e-05 | 954 | 91 | 11 | 36373674 |
| Pubmed | Localization of the murine Hmg1 gene, encoding an HMG-box protein, to mouse chromosome 2. | 4.05e-05 | 4 | 91 | 2 | 8268661 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 17449030 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 10504338 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 29581310 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 4.52e-05 | 148 | 91 | 5 | 32538781 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 4.81e-05 | 495 | 91 | 8 | 28581483 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.95e-05 | 497 | 91 | 8 | 36774506 | |
| Pubmed | HSPD1 RANBP2 GNL3L ZMPSTE24 NDC80 ABCE1 PRRC2C FANCI CNTRL AP3B1 ADAR ACSL5 | 5.33e-05 | 1168 | 91 | 12 | 19946888 | |
| Pubmed | 5.47e-05 | 653 | 91 | 9 | 22586326 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | HSPD1 RANBP2 GNL3L TXNDC5 FANCI GARS1 SLTM EIF3C ADAR SDAD1 FTSJ3 | 5.53e-05 | 989 | 91 | 11 | 36424410 |
| Pubmed | 5.60e-05 | 655 | 91 | 9 | 35819319 | ||
| Pubmed | 6.32e-05 | 259 | 91 | 6 | 31162944 | ||
| Pubmed | 6.68e-05 | 30 | 91 | 3 | 34780058 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 9722593 | ||
| Pubmed | EHMT2 and SETDB1 protect the maternal pronucleus from 5mC oxidation. | 6.74e-05 | 5 | 91 | 2 | 31088968 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 17959718 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 12434308 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSPD1 PDIA4 MFAP1 RANBP2 TXNDC5 SLTM EIF3C CTTN ADAR PPP1CA FTSJ3 | 7.54e-05 | 1024 | 91 | 11 | 24711643 |
| Pubmed | 8.51e-05 | 397 | 91 | 7 | 21319273 | ||
| Pubmed | HSPD1 PDIA4 MFAP1 SETDB1 ZMPSTE24 PRRC2C PPP1R13B HMGB1 EIF3C CTTN SDAD1 PPP1CA FTSJ3 | 8.76e-05 | 1429 | 91 | 13 | 35140242 | |
| Pubmed | HSPD1 RANBP2 TXNDC5 ABCE1 GARS1 HMGB1 OAT CTTN AP3B1 ARAF PPP1CA FTSJ3 | 9.92e-05 | 1247 | 91 | 12 | 27684187 | |
| Pubmed | Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins. | 1.01e-04 | 6 | 91 | 2 | 23088536 | |
| Pubmed | Role of Fgf10 in cell proliferation in white adipose tissue. | 1.01e-04 | 6 | 91 | 2 | 16513252 | |
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 21998301 | ||
| Pubmed | 1.01e-04 | 708 | 91 | 9 | 39231216 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HSPD1 RANBP2 GNL3L ABCE1 FANCI GARS1 OAT NUB1 EIF3C NEK9 EIF3CL PPP1CA | 1.07e-04 | 1257 | 91 | 12 | 37317656 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.08e-04 | 714 | 91 | 9 | 28302793 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.11e-04 | 179 | 91 | 5 | 36261009 | |
| Pubmed | 1.13e-04 | 288 | 91 | 6 | 38496616 | ||
| Pubmed | Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC. | 1.16e-04 | 36 | 91 | 3 | 16097034 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.20e-04 | 724 | 91 | 9 | 36232890 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 1.20e-04 | 565 | 91 | 8 | 33567341 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSPD1 SLC25A24 MFAP1 RANBP2 SLTM HMGB1 EIF3C ADAR SDAD1 PPP1CA SYNGAP1 | 1.23e-04 | 1082 | 91 | 11 | 38697112 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 1.24e-04 | 422 | 91 | 7 | 27342126 | |
| Interaction | BIRC3 interactions | HSPD1 PDIA4 SLC25A24 RANBP2 GNL3L TXNDC5 ABCE1 FANCI GARS1 SLTM HMGB1 OAT TDRD6 MDH1 CTTN AP3B1 ADAR NEK9 EIF3CL PPP1CA FTSJ3 | 3.05e-07 | 1334 | 90 | 21 | int:BIRC3 |
| Interaction | ECI1 interactions | 3.29e-06 | 91 | 90 | 6 | int:ECI1 | |
| Interaction | H1-5 interactions | PDIA4 MFAP1 DIP2A ZMPSTE24 CNTRL H1-5 UTP23 HMGB1 NEK9 EIF3CL FTSJ3 | 6.79e-06 | 463 | 90 | 11 | int:H1-5 |
| Interaction | AURKA interactions | HSPD1 TXNDC5 SPI1 NDC80 PRRC2C CNTRL MDH1 CTTN STX17 NEK9 SDAD1 PPP1CA AKR7A2 | 1.26e-05 | 696 | 90 | 13 | int:AURKA |
| Interaction | BAP1 interactions | HSPD1 PDIA4 RANBP2 NPHP3 TXNDC5 PRRC2C FANCI GARS1 HMGB1 MDH1 CTTN AP3B1 ADAR NEK9 EIF3CL PPP1CA AKR7A2 FTSJ3 | 1.71e-05 | 1314 | 90 | 18 | int:BAP1 |
| Interaction | OAS3 interactions | 1.75e-05 | 72 | 90 | 5 | int:OAS3 | |
| Interaction | PSPC1 interactions | MFAP1 NDC80 ABCE1 PRRC2C EIF3C CTTN ADAR TET3 SDAD1 PPP1CA FTSJ3 | 1.84e-05 | 515 | 90 | 11 | int:PSPC1 |
| Interaction | HMGB1P1 interactions | 2.44e-05 | 38 | 90 | 4 | int:HMGB1P1 | |
| Interaction | SNW1 interactions | HSPD1 STK10 MFAP1 RANBP2 NDC80 RBL2 FANCI CAPG HMGB1 CTTN AP3B1 PPP1CA FTSJ3 | 2.66e-05 | 747 | 90 | 13 | int:SNW1 |
| Interaction | DVL2 interactions | HSPD1 ARR3 FANCI ITSN1 GARS1 FER PPP1R13B ADAR ARAF PPP1CA DNAH11 | 3.76e-05 | 557 | 90 | 11 | int:DVL2 |
| Interaction | MYLK4 interactions | 5.18e-05 | 90 | 90 | 5 | int:MYLK4 | |
| Interaction | OPN1MW2 interactions | 5.90e-05 | 3 | 90 | 2 | int:OPN1MW2 | |
| Interaction | AGR2 interactions | HSPD1 PDIA4 SLC25A24 ZMPSTE24 TXNDC5 ABCE1 CNTRL GARS1 H1-5 SLTM HMGB1 MDH1 AP3B1 PPP1CA | 6.48e-05 | 934 | 90 | 14 | int:AGR2 |
| Interaction | WDR5 interactions | HSPD1 PDIA4 RANBP2 TXNDC5 ABCE1 PRRC2C GARS1 HMGB1 OAT DDX60L EIF3C TNS1 SDAD1 ACSL5 SLC27A2 | 1.01e-04 | 1101 | 90 | 15 | int:WDR5 |
| Interaction | CCNB1 interactions | 1.11e-04 | 244 | 90 | 7 | int:CCNB1 | |
| Interaction | GSK3B interactions | HSPD1 PDIA4 VPS13D SPI1 ABCE1 PRRC2C GARS1 NUB1 EIF3C MDH1 CTTN PPP1CA SYNGAP1 | 1.22e-04 | 868 | 90 | 13 | int:GSK3B |
| Interaction | RPS24 interactions | MFAP1 GNL3L FANCI HMGB1 EIF3C CTTN SDAD1 EIF3CL PPP1CA FTSJ3 | 1.24e-04 | 529 | 90 | 10 | int:RPS24 |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.58e-04 | 115 | 53 | 4 | 769 | |
| GeneFamily | Protein disulfide isomerases | 1.71e-03 | 21 | 53 | 2 | 692 | |
| GeneFamily | Acyl-CoA synthetase family | 2.62e-03 | 26 | 53 | 2 | 40 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 174 | 90 | 6 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 174 | 90 | 6 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 182 | 90 | 6 | 942c18a27b22fb33a5200d5717cad972f3ef0576 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-06 | 195 | 90 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Large_pre-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.99e-06 | 197 | 90 | 6 | 7e0834b3947031bf244a10624dcf3f2095c79368 | |
| ToppCell | Mild/Remission-Developping_Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.17e-06 | 199 | 90 | 6 | 58c772ec763109a4009f52424fbb214fc23d0c09 | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.27e-06 | 200 | 90 | 6 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | Severe-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.27e-06 | 200 | 90 | 6 | 80639e0d2ddaae36ac7634a4f03e8809af7316e3 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 158 | 90 | 5 | b0508a600994090c6aafd8d779437190a33ad821 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-05 | 158 | 90 | 5 | a816cc095452308d06f87b77467e2a8c6361fd2a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.13e-05 | 165 | 90 | 5 | 731147b4337fd0de4383dc8170b4f9ccd98caec6 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 165 | 90 | 5 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 165 | 90 | 5 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-05 | 168 | 90 | 5 | 93b7138f17aa14a6398c9b4ea7237781a0e19a66 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-05 | 168 | 90 | 5 | e393553208617a023f1646169c892a87c95db3f5 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-05 | 168 | 90 | 5 | 00cff4698db14e03ca1d1b409e5ed1ad23b12615 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.39e-05 | 169 | 90 | 5 | 90c00ab30e582b0e2a2be751e1fae9024cfb9ea6 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 176 | 90 | 5 | 2e9073166da4d9fae70ba4f3fdcad35523caf7cd | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-05 | 176 | 90 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.15e-05 | 179 | 90 | 5 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 3.15e-05 | 179 | 90 | 5 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 183 | 90 | 5 | 0513bb73552bfee609877d924fa97684200f595c | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 183 | 90 | 5 | 6eeef55071ae25a61616df4fcfb2cea560aa7923 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 183 | 90 | 5 | 85b2335fa938a94e74251bd8d99de1bd21265ac9 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.78e-05 | 186 | 90 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 4.08e-05 | 189 | 90 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.51e-05 | 193 | 90 | 5 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.51e-05 | 193 | 90 | 5 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Pro-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 194 | 90 | 5 | 58d7c56d2b9c893b62da2334428d677e3451fe07 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.62e-05 | 194 | 90 | 5 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.62e-05 | 194 | 90 | 5 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-05 | 195 | 90 | 5 | db1660ce74819cd816bdcfcae5efb3aad82cce66 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.85e-05 | 196 | 90 | 5 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.85e-05 | 196 | 90 | 5 | e4f40274df940e0996c555082f2bb4f99e5b0881 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-05 | 196 | 90 | 5 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.85e-05 | 196 | 90 | 5 | 7e98380d815fbf6254289ace2af37aac6fef51e8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 4.85e-05 | 196 | 90 | 5 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | suprabasal_cell|World / shred by cell class for bronchial biopsy | 4.85e-05 | 196 | 90 | 5 | 3c1fa7ec1c7e02b45b2c5843d2c5b2063cd13be8 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 196 | 90 | 5 | d4df86ce289835e76763213641989fde77935a16 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.85e-05 | 196 | 90 | 5 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 4.85e-05 | 196 | 90 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.97e-05 | 197 | 90 | 5 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.97e-05 | 197 | 90 | 5 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.97e-05 | 197 | 90 | 5 | b754fad4f3caae6de95df901fd96ea8697fe41b1 | |
| ToppCell | mLN-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 4.97e-05 | 197 | 90 | 5 | bd1d01d6c49f68f5c85d84df96c90dd04b9de09b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.97e-05 | 197 | 90 | 5 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 4.97e-05 | 197 | 90 | 5 | d8dc65b580191827ab6bbad5e29f0089419ebaef | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.97e-05 | 197 | 90 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.09e-05 | 198 | 90 | 5 | a35b43d38e18c6f8f0cd9015b8e23f71c729f023 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_macrophage|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.09e-05 | 198 | 90 | 5 | c08018f099a381a66993cb60288954a6e47f105f | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.09e-05 | 198 | 90 | 5 | 27cc7f786fb8cb230589d762a4e51b46265c1f19 | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 5.09e-05 | 198 | 90 | 5 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-05 | 198 | 90 | 5 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.09e-05 | 198 | 90 | 5 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.22e-05 | 199 | 90 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Skin-Mesangial|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 5.22e-05 | 199 | 90 | 5 | bcb78838a91cc7828680fb413fbacdb091c5fac0 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.22e-05 | 199 | 90 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | hematopoetic_progenitors-CD34+_MPP|hematopoetic_progenitors / Lineage and Cell class | 5.22e-05 | 199 | 90 | 5 | ec127c5a374a005ecf1377fb9bd245a7244505bf | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-05 | 199 | 90 | 5 | 0649a2c5b8b1f01bb4c4d1eb114cf78a32f8ccd8 | |
| ToppCell | PBMC-Severe|PBMC / Compartment, Disease Groups and Clusters | 5.22e-05 | 199 | 90 | 5 | b428d95d3c90b28f658f652a768588a8ced4abd9 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.22e-05 | 199 | 90 | 5 | e3e28981783b922027cee7fe8863386b02c7c758 | |
| ToppCell | Mild/Remission-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.22e-05 | 199 | 90 | 5 | 1dda6116de639140c2d6f5012b7ab9ad0f737ae1 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.34e-05 | 200 | 90 | 5 | 7c56935446f10d202eafa1f9ee7cb0aae4c2607e | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 5.34e-05 | 200 | 90 | 5 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 5.34e-05 | 200 | 90 | 5 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.34e-05 | 200 | 90 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.34e-05 | 200 | 90 | 5 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 5.34e-05 | 200 | 90 | 5 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 90 | 5 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.34e-05 | 200 | 90 | 5 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.34e-05 | 200 | 90 | 5 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.34e-05 | 200 | 90 | 5 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 134 | 90 | 4 | a632d78890fcc20db81d2cf6b299470706d2e182 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 134 | 90 | 4 | 8be2db71d9d29f9a57a64efdc89cf8c3e32b363b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.78e-04 | 54 | 90 | 3 | 7670a6eb185ae0d8c3c0cb17f8eaa9970355187b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.78e-04 | 54 | 90 | 3 | 79f804e73f859c0e8192d9e9e6ee2282f7f1691b | |
| ToppCell | Control-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.13e-04 | 145 | 90 | 4 | fe68582f5a15b9714cb84fa32ac880e13cb69895 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.49e-04 | 151 | 90 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-04 | 157 | 90 | 4 | 904cd98ae85ed6459e0663f077ac462842bf12df | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 157 | 90 | 4 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 157 | 90 | 4 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.89e-04 | 157 | 90 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.96e-04 | 158 | 90 | 4 | b35bab2b93d0af821bfae18a358eb7dddaf3860f | |
| ToppCell | Leuk-UTI-Lymphocyte-B-Plasmablast|Leuk-UTI / Disease, Lineage and Cell Type | 2.96e-04 | 158 | 90 | 4 | 05a29c2d5506a25ccdfa4c6a86e9188977a18272 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.96e-04 | 158 | 90 | 4 | 7bd4a64a610eb1cbcd3d07ea5258a55107cf6c00 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 160 | 90 | 4 | 0b8151037b28f52a21918856a1e9336e8d5edb90 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.10e-04 | 160 | 90 | 4 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 160 | 90 | 4 | 4738d0c73d8c3508e5b5beb6c61e0ad551d9b949 | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, Lineage and Cell Type | 3.18e-04 | 161 | 90 | 4 | 8ca34d800551cb0f796293e6bfdcbf58509cc668 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Vipr2_(central_amygdaloid_nucleus,_medial_division,_anterodorsal_part_(CeMAD))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.23e-04 | 66 | 90 | 3 | 6db3933fde0eee67dc5da85d7008c4fef9f684f5 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Vipr2_(central_amygdaloid_nucleus,_medial_division,_anterodorsal_part_(CeMAD))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.23e-04 | 66 | 90 | 3 | c522722e99922caf4abe7103f1492ea96d3786a5 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Vipr2_(central_amygdaloid_nucleus,_medial_division,_anterodorsal_part_(CeMAD))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.23e-04 | 66 | 90 | 3 | c6888ebcaba37486d9a12ad4d76669fb4e3c8fba | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 162 | 90 | 4 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 162 | 90 | 4 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.25e-04 | 162 | 90 | 4 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.25e-04 | 162 | 90 | 4 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-04 | 164 | 90 | 4 | cd0794f84dfd346807e2d803723718b7f22e9232 | |
| Drug | 4-amino-2,6-dinitrotoluene | HSPD1 PDIA4 GNL3L SBNO1 ABCE1 GARS1 HMGB1 OAT ATP8B2 SDAD1 AKR7A2 FTSJ3 | 1.46e-06 | 541 | 90 | 12 | ctd:C035207 |
| Disease | hydrocephalus (biomarker_via_orthology) | 1.37e-04 | 6 | 90 | 2 | DOID:10908 (biomarker_via_orthology) | |
| Disease | C-reactive protein measurement | RGS6 SPI1 SBNO1 SLC38A4 SPATA16 DHRS9 EIF3C ADAR ATP8B2 EIF3CL DNAH11 | 1.10e-03 | 1206 | 90 | 11 | EFO_0004458 |
| Disease | Liver Cirrhosis, Experimental | 2.53e-03 | 774 | 90 | 8 | C0023893 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLLTGKYKYEDKDGK | 231 | O43488 | |
| SLSKDGGKKFKYIEN | 106 | Q7Z7A1 | |
| LKKAYELIKSANLGK | 21 | Q8IYW2 | |
| LKLSSKGQKLDAYKR | 106 | Q7L190 | |
| KGDLFTKKYKLIQGD | 866 | Q96DT5 | |
| AKSIDLKDKYKNIGA | 81 | P10809 | |
| GKELKNGKKLESLSY | 441 | Q6DHV5 | |
| KYKKLLKQNSGGQEG | 171 | Q92988 | |
| KKGKLNGFQSYNGKL | 246 | Q96KQ4 | |
| KKTSSNGKLSIYLGK | 6 | P36575 | |
| QLIEYGKKSGKKAGD | 216 | Q96DT6 | |
| KSGALSKYAKKIFLA | 586 | O00203 | |
| KKYKKAVTLAIGDGA | 821 | P98198 | |
| VKKLNGKLYLDGSEK | 2681 | P49792 | |
| AYQDLLLAKKKGKSL | 446 | P49758 | |
| NKKVGLALKDLAKQY | 31 | Q9Y5A7 | |
| YEKKLLKGKEENLTG | 306 | Q08999 | |
| KTKVSYLKQKGLGGA | 341 | Q13231 | |
| ALATKKENLAYGKGV | 136 | Q9NVI1 | |
| KSLNYTGEKKEKPAA | 1221 | Q9NVI1 | |
| KIYQANGKQKKAGVA | 61 | O00370 | |
| ANGKVITNKAVKGKY | 321 | P55081 | |
| AYRAKGKPDAAKKGV | 161 | P09429 | |
| KANLIKLGDYGLAKK | 186 | Q8TD19 | |
| KRNASKKGKLAEYGA | 211 | Q9GZZ0 | |
| AGGDNSKLRYKKKGS | 1021 | Q9UBC5 | |
| GDDKNKKKYSIDIGP | 701 | Q5H9U9 | |
| YSKGFQEGLKKTKEL | 776 | Q9Y6F6 | |
| SQGAALDKYAKKSVK | 111 | P40925 | |
| HEDYGLSITKGKKAK | 266 | P31512 | |
| KAAYSLLGSQKSGKL | 1236 | Q9C091 | |
| KLLRKSTFKNAKLYG | 251 | Q9Y251 | |
| FLLGDSQPVKYGKKK | 276 | A8MWK0 | |
| LKPADKNKGKYGQFS | 296 | P62136 | |
| LGKAYGKAKSIVDKE | 86 | Q99613 | |
| LGKAYGKAKSIVDKE | 86 | B5ME19 | |
| KILAGKQKPNLGKYD | 121 | P61221 | |
| DDKKKVKNLGYRDSG | 286 | P10398 | |
| GSFKLNKKAASGEAK | 106 | P16401 | |
| SLEKAKKELGYKAQP | 326 | Q8WUS8 | |
| LYSLAKKGKLQKEAG | 176 | P55265 | |
| KGNFGEVYKGTLKDK | 571 | P16591 | |
| SGKLYKAKSNKELYG | 1466 | Q15811 | |
| KGTNVFKGYLKDPEK | 496 | Q9ULC5 | |
| GAPAAIKKLYQVKGK | 131 | P40121 | |
| TKYFLKIEKNGKVSG | 86 | O15520 | |
| HLKGVIKAKYGKDAT | 191 | P13929 | |
| KELKGGKAYAKLGFA | 86 | Q5T8I3 | |
| GDITQKGYEKKRAKL | 31 | Q14689 | |
| GFVGSKLKKKYKNSE | 131 | Q9NVP4 | |
| FAKKLGKAKDLYSAL | 421 | O75844 | |
| GKAKDLYSALIKLNK | 426 | O75844 | |
| GYIEKSLDKLKGNKS | 241 | Q9BPW9 | |
| LNKFKYGKISSKHNG | 376 | A3KN83 | |
| GSKNAKKEYMGLAIK | 886 | Q16363 | |
| TLGKDLYGAKLIAQK | 71 | Q9BRU9 | |
| YIALQKKKKSGLTGV | 101 | Q9C093 | |
| GSYNLDVGLKKLSNK | 1721 | O60522 | |
| IHQKAIKKKGNLYGF | 1056 | Q7Z494 | |
| NGYAGAKAQTEKKKL | 436 | O14975 | |
| VAHRLGKKKKGGLYS | 366 | Q9NVN8 | |
| GKKKKGGLYSQEQAA | 371 | Q9NVN8 | |
| ALGEKKKEKLEALYG | 276 | A1L4K1 | |
| FLKSDKNRIGGTYKK | 61 | Q9BQS7 | |
| QFEPSKGAIGKAYKK | 496 | P41250 | |
| KGAIGKAYKKDAKLV | 501 | P41250 | |
| AYQAKGKPEAAKKGV | 161 | B2RPK0 | |
| GQSTKAKDGKKYATL | 6 | Q9Y520 | |
| KAADLKNLFGKYGKV | 396 | Q9NWH9 | |
| KNLFGKYGKVLSAKV | 401 | Q9NWH9 | |
| QLRSLYKKAGLGKEK | 781 | Q8IY81 | |
| LGFKNKDDGKFLEKI | 386 | Q9BXB7 | |
| NSLAKKYKGQKGLVI | 566 | P13667 | |
| KELDAAPGKSQKRKY | 566 | Q9NVU7 | |
| ALRNYGKTGEVKKVK | 231 | P17947 | |
| KQKLDSKELGKYGLL | 206 | Q9NTN3 | |
| KFLTNGFLGKKKLAD | 51 | Q969I6 | |
| TKTLLKKDKYSLAGG | 126 | O00570 | |
| KKDKYSLAGGLLAAG | 131 | O00570 | |
| KGIQKYKAKIVFAAG | 161 | P04181 | |
| KVKFDNKGKSLLSGN | 231 | Q15047 | |
| EAYSGANGILKKVKK | 111 | P31937 | |
| YGKHLKKLDSFDLKG | 251 | Q7L1S5 | |
| SDKKRKKDKAGYVGL | 331 | Q96PV0 | |
| GGKYGIDKDKVDKSA | 196 | Q14247 | |
| EGTKNLGKAAKYKLA | 216 | P56962 | |
| YKAKNKETGALAAAK | 51 | O94804 | |
| LDGSLYAKVKKKDSL | 361 | Q9HBL0 | |
| GKKKAEIAAEYGIKK | 36 | Q8IY51 | |
| GGYSLKLSKLKKNDS | 86 | Q9NQ25 | |
| GLGQQEAKLYGKKRK | 1731 | O43151 | |
| SAYVKNLKKGNIVKG | 246 | Q9ULT0 | |
| GKKVDQYKGKRDLES | 271 | Q8NBS9 | |
| ESYKKLFLQSGGKRK | 161 | P0C1S8 | |
| AKKILKHEGLGAFYK | 331 | Q6NUK1 | |
| YFNKLKGGLLSTDDK | 356 | Q5THJ4 | |
| ALLGLFKKKGSAKAE | 11 | Q9P206 | |
| FSYLVGDSGKKKLVK | 511 | Q5T7N2 | |
| RGILKCKKDKAYEGG | 236 | Q9NR99 | |
| KLKLIPKGAENSKGY | 421 | O14777 |